Christina Proulx
Nurse Practitioner · Denver, CONPI 1164001418
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. TG Therapeutics, Inc. accounts for 81.1% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $10,950, more than ten times the $519 reported in 2021. Among nurse practitioner clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $96.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TG Therapeutics, Inc.$23K
- Biogen$2K
- EMD Serono, Inc.$612
- Sanofi$598
- Novartis$558
- Bristol Myers Squibb$367
- plus $1K from 20 others
Across 24 payments — averaging $8068.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- TG Therapeutics, Inc.$194K
What the payments were for
- Consulting fees$2,3008%
- Speaking & faculty fees$14,51352%
- Travel & lodging$2,67110%
- Food & beverage$8,39030%
- Education$1641%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TG Therapeutics, Inc. | 116 | $22,746 |
| Biogen | 65 | $1,737 |
| EMD Serono, Inc. | 19 | $612 |
| Sanofi | 13 | $598 |
| Novartis | 18 | $558 |
| Bristol Myers Squibb | 6 | $367 |
| Vanda Pharmaceuticals Inc. | 5 | $260 |
| AbbVie | 9 | $208 |
| AstraZeneca | 5 | $174 |
| Genentech USA, Inc. | 6 | $147 |
| Lundbeck LLC | 4 | $97 |
| Amgen | 3 | $77 |
| Medtronic | 2 | $61 |
| Acorda Therapeutics, Inc | 2 | $56 |
| Mallinckrodt Hospital Products Inc. | 2 | $50 |
| Banner Life Sciences, LLC | 3 | $47 |
| Lilly USA, LLC | 2 | $37 |
| Saol Therapeutics Inc. | 1 | $37 |
| Grifols USA, LLC | 2 | $35 |
| Johnson & Johnson | 1 | $24 |
| Mylan Specialty L.p. | 1 | $21 |
| Kedrion Biopharma Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Cycle Pharmaceuticals Inc | 1 | $17 |
| UCB, Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,037 in reported general payments places this provider in the 95th percentile of 1,384 nurse practitioner providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 11 | $26,098 |
| Dalfampridine ErDalfampridine | 57 | $16,865 |
| Baclofen | 121 | $4,074 |
| Gabapentin | 96 | $2,650 |
| Pregabalin | 36 | $1,958 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 27 | $1,931 |
| Modafinil | 20 | $640 |
| Carbamazepine ErCarbamazepine | 11 | $630 |
| Clonazepam | 29 | $459 |
| Tizanidine Hcl | 20 | $384 |
| Duloxetine Hcl | 13 | $264 |
| Diazepam | 26 | $224 |
| Amitriptyline Hcl | 13 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $208 | $26,09811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,384 nurse practitioner providers in Colorado.
Other nurse practitioner in Denver
- Jose Diaz LeoDenver$24K
- Lolanda McBrideDenver$20K
- Cori FratelliDenver$15K
- Leslie HindsDenver$9K
- Rebecca AndrieDenver$8K
- Nahid Kuseh Kalani YazdDenver$8K
- Amber Whitton-SmithDenver$7K
- Jacqueline CarboneDenver$7K
- Stephanie WyttenbachDenver$7K
- Dana HammondsDenver$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.